Cite
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions.
MLA
Laufer, Rachel S., et al. “Cost-Effectiveness of Infant Respiratory Syncytial Virus Preventive Interventions in Mali: A Modeling Study to Inform Policy and Investment Decisions.” Vaccine, vol. 39, no. 35, Aug. 2021, pp. 5037–45. EBSCOhost, https://doi.org/10.1016/j.vaccine.2021.06.086.
APA
Laufer, R. S., Driscoll, A. J., Baral, R., Buchwald, A. G., Campbell, J. D., Coulibaly, F., Diallo, F., Doumbia, M., Galvani, A. P., Haidara, F. C., Kotloff, K. L., Keita, A. M., Neuzil, K. M., Orenstein, E. W., Orenstein, L. A. V., Pecenka, C., Sow, S., Tapia, M. D., Ortiz, J. R., & Fitzpatrick, M. C. (2021). Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions. Vaccine, 39(35), 5037–5045. https://doi.org/10.1016/j.vaccine.2021.06.086
Chicago
Laufer, Rachel S., Amanda J. Driscoll, Ranju Baral, Andrea G. Buchwald, James D. Campbell, Flanon Coulibaly, Fatoumata Diallo, et al. 2021. “Cost-Effectiveness of Infant Respiratory Syncytial Virus Preventive Interventions in Mali: A Modeling Study to Inform Policy and Investment Decisions.” Vaccine 39 (35): 5037–45. doi:10.1016/j.vaccine.2021.06.086.